Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Unusually-High Trading Volume - Time to Buy?

Key Points

• Trading activity increased substantially: About 107,552 SGIOY shares changed hands, although volume was 19% below the prior session. The ADR fell to $9.08 from a $9.32 close.
• Analyst sentiment is favorable: Goldman Sachs and Jefferies upgraded the stock to “strong buy,” while Zacks Research moved its rating from “strong sell” to “hold.” MarketBeat data shows an overall “Buy” rating.
• Quarterly results beat expectations: Shionogi reported $0.36 in EPS versus the $0.18 consensus estimate and revenue of $1.04 billion versus $970.69 million expected, supported by a 46.67% net margin.

Shares of Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) saw unusually-high trading volume on Thursday . Approximately 107,552 shares were traded during trading, a decline of 19% from the previous session's volume of 132,895 shares.The stock last traded at $9.08 and had previously closed at $9.32.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research report on Monday, June 15th. Zacks Research raised shares of Shionogi & Co., Ltd. Unsponsored ADR from a "strong sell" rating to a "hold" rating in a research note on Monday, May 25th. Finally, Jefferies Financial Group upgraded Shionogi & Co., Ltd. Unsponsored ADR from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, July 14th. Two equities research analysts have rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy".

Shionogi & Co., Ltd. Unsponsored ADR Stock Up 0.2%

The stock has a fifty day moving average of $8.96 and a 200-day moving average of $9.62. The firm has a market capitalization of $15.39 billion, a price-to-earnings ratio of 9.04, a PEG ratio of 3.34 and a beta of 0.08. The company has a current ratio of 1.58, a quick ratio of 1.46 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) last announced its earnings results on Monday, August 3rd. The company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.18 by $0.18. The company had revenue of $1.04 billion during the quarter, compared to analysts' expectations of $970.69 million. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 46.67% and a return on equity of 16.47%. As a group, sell-side analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.82 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that researches, develops, manufactures and markets prescription medicines. Founded in Osaka in 1878, the company has built its business around drug discovery and has a particular focus on infectious diseases, including antiviral and antibacterial treatments.

Shionogi's products include Xofluza (baloxavir marboxil), an oral treatment for influenza, and Fetcroja (cefiderocol), an antibiotic used for certain difficult-to-treat bacterial infections.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.